I

Intensity Therapeutics Inc
NASDAQ:INTS

Watchlist Manager
Intensity Therapeutics Inc
NASDAQ:INTS
Watchlist
Price: 0.4104 USD -1.75% Market Closed
Market Cap: 24.6m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of INTS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INTS Intrinsic Value
Not Available
Base Case Scenario
Compare INTS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INTS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Intensity Therapeutics Inc

Current Assets 8.2m
Cash & Short-Term Investments 7.1m
Other Current Assets 1.1m
Non-Current Assets 1.4m
PP&E 103k
Other Non-Current Assets 1.3m
Current Liabilities 2.3m
Accounts Payable 1.7m
Accrued Liabilities 592k
Non-Current Liabilities 87k
Other Non-Current Liabilities 87k
Efficiency

Free Cash Flow Analysis
Intensity Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Intensity Therapeutics Inc

Revenue
0 USD
Operating Expenses
-12m USD
Operating Income
-12m USD
Other Expenses
299k USD
Net Income
-11.7m USD
Fundamental Scores

INTS Profitability Score
Profitability Due Diligence

Intensity Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Intensity Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

INTS Solvency Score
Solvency Due Diligence

Intensity Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Intensity Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INTS Price Targets Summary
Intensity Therapeutics Inc

Wall Street analysts forecast INTS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INTS is 2.975 USD with a low forecast of 1.515 USD and a high forecast of 5.25 USD.

Lowest
Price Target
1.515 USD
269% Upside
Average
Price Target
2.975 USD
625% Upside
Highest
Price Target
5.25 USD
1 179% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Intensity Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for INTS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y